BioCardia, Inc.   Report issue

For profit Phase 3
Founded: San Carlos CA United States (1999)
Status: Left NME R&D (2021)

Organization Overview

First Clinical Trial
2016
NCT02438306
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

BioCardia, Inc.